CannPal progressing canine cannabinoid trials.  (Phase 2A pilot dose determination study for canine osteoarthritis and DermaCann trial starting soon.) For more information:

https://hempgazette.com/news/cannpal-cannabis-trials-hg0971/

_____________________________________________

Penn Vet to study hemp-based supplement. For more information:

https://www.veterinarypracticenews.com/penn-vet-study-hemp-based-canine-supplement/

_______________________________________________

Canopy Growth announces clinical trial approval for the use of cannabis to treat anxiety in certain animals.  For more information:

https://www.canopygrowth.com/wp-content/uploads/2018/08/20180802_CAH-Anxiety-Study-NR-Final-EN-1.pdf


CannPal Animal Therapeutics commences Phase 1B of the Pharmacokinetic and Safety study for CPAT-01D, a cannabis-derived pain control for dogs.  For more information:

https://www.americanveterinarian.com/news/first-cannabinoid-animal-drug-garners-favorable-study-results

 


For a handy chart of just some of the many studies currently underway in the US, refer to the article in AAHA Trends magazine titled:

"How Expanded Research Is Clearing Up Cannabis Confusion"  by Sarah  Rumple

http://www.aaha.org/blog/NewStat/post/2019/02/21/372460/A-Growing-Case-for-Cannabis.aspx#.XG8itUWv6nw